Sign In
Buy PRVA
$22.37
-0.0800 (-0.356%)
At Close: Aug 10, 2026
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
04:10pm, Tuesday, 23'rd Sep 2025
Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path. Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to
Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
04:10pm, Tuesday, 23'rd Sep 2025
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business f
– Mid-Atlantic ACO Realized Highest Savings Rate of All ACOs with 40,000+ Attributed Lives – Company Increases Adjusted EBITDA Guidance for Full-Year 2025 ARLINGTON, Va., Aug. 28, 2025 (GLOBE NEW
Privia Health Group, Inc. (PRVA) Q2 2025 Earnings Call Transcript
11:01pm, Thursday, 07'th Aug 2025
Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants David Mountcastle - Executive VP, CFO & Principal Accounting Officer Parth Mehr
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
10:32am, Thursday, 07'th Aug 2025
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall St
Privia Health (PRVA) Misses Q2 Earnings Estimates
08:11am, Thursday, 07'th Aug 2025
Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.03 per share a year ago.
Privia Health Reports Second Quarter 2025 Financial Results
06:00am, Thursday, 07'th Aug 2025
Strong Performance Across Key Metrics; Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution, Adj EBITDA
Privia Health to Report Second Quarter 2025 Results on Thursday, August 7
09:00am, Thursday, 10'th Jul 2025
ARLINGTON, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods end
Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors
09:00am, Tuesday, 08'th Jul 2025
Berberian brings significant technology leadership and cybersecurity expertise Berberian brings significant technology leadership and cybersecurity expertise
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript
03:44am, Sunday, 11'th May 2025
Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Part
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say
10:36am, Thursday, 08'th May 2025
While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics com
Privia Health (PRVA) Misses Q1 Earnings Estimates
08:20am, Thursday, 08'th May 2025
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.
Privia Health Reports First Quarter 2025 Financial Results
06:00am, Thursday, 08'th May 2025
Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchange
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Wednesday, 07'th May 2025
Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates fo
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
07:03am, Tuesday, 04'th Mar 2025
With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings
